These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 24991604)
1. Side effects of antineoplastic and immunomodulating medications reported by European consumers. Aagaard L; Hansen EH J Res Pharm Pract; 2013 Jan; 2(1):44-9. PubMed ID: 24991604 [TBL] [Abstract][Full Text] [Related]
2. Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011. Aagaard L; Hansen EH BMC Pharmacol Toxicol; 2013 Jun; 14():30. PubMed ID: 23763896 [TBL] [Abstract][Full Text] [Related]
3. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Aagaard L; Nielsen LH; Hansen EH Drug Saf; 2009; 32(11):1067-74. PubMed ID: 19810778 [TBL] [Abstract][Full Text] [Related]
4. Adverse drug reactions in children reported by European consumers from 2007 to 2011. Aagaard L; Hansen EH Int J Clin Pharm; 2014 Apr; 36(2):295-302. PubMed ID: 24190692 [TBL] [Abstract][Full Text] [Related]
5. Paediatric adverse drug reactions following use of asthma medications in Europe from 2007 to 2011. Aagaard L; Hansen EH Int J Clin Pharm; 2014 Dec; 36(6):1222-9. PubMed ID: 25288145 [TBL] [Abstract][Full Text] [Related]
6. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBaseā¢. Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620 [TBL] [Abstract][Full Text] [Related]
7. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Aagaard L; Weber CB; Hansen EH Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864 [TBL] [Abstract][Full Text] [Related]
8. Side effects reported by European consumers for medications for erectile dysfunction. Aagaard L; Hansen EH J Res Pharm Pract; 2013 Apr; 2(2):93-5. PubMed ID: 24991611 [TBL] [Abstract][Full Text] [Related]
9. Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance. Aagaard L; Hallgreen CE; Hansen EH Int J Obes (Lond); 2016 Nov; 40(11):1742-1747. PubMed ID: 27478924 [TBL] [Abstract][Full Text] [Related]
10. Patterns of adverse drug reactions (ADRs) in Saudi Arabia. Bin Yousef N; Yenugadhati N; Alqahtani N; Alshahrani A; Alshahrani M; Al Jeraisy M; Badri M Saudi Pharm J; 2022 Jan; 30(1):8-13. PubMed ID: 35145342 [TBL] [Abstract][Full Text] [Related]
11. What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association. Vilhelmsson A; Svensson T; Meeuwisse A; Carlsten A BMC Clin Pharmacol; 2011 Oct; 11():16. PubMed ID: 22026961 [TBL] [Abstract][Full Text] [Related]
12. [Adverse drug reaction reports in Iceland from 2013 to 2016. A comparison with other Nordic countries]. Jonsdottir SS; Olafsdottir SM; Gudmundsdottir H Laeknabladid; 2017 Jul; 103(07-08):319-323. PubMed ID: 28816174 [TBL] [Abstract][Full Text] [Related]
13. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database. Castillon G; Salvo F; Moride Y Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742 [TBL] [Abstract][Full Text] [Related]
14. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals. Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL; Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189 [TBL] [Abstract][Full Text] [Related]
15. Paradoxical adverse drug reactions: descriptive analysis of French reports. Hakimi Y; Petitpain N; Pinzani V; Montastruc JL; Bagheri H Eur J Clin Pharmacol; 2020 Aug; 76(8):1169-1174. PubMed ID: 32418024 [TBL] [Abstract][Full Text] [Related]
16. Monitoring drug safety in Astrakhan, Russia. Kirilochev OO; Dorfman IP; Umerova AR Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758 [TBL] [Abstract][Full Text] [Related]
18. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions. Aagaard L; Hansen EH Br J Clin Pharmacol; 2011 May; 71(5):751-7. PubMed ID: 21241353 [TBL] [Abstract][Full Text] [Related]
19. Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database. Magro L; Arzenton E; Leone R; Stano MG; Vezzaro M; Rudolph A; Castagna I; Moretti U Front Pharmacol; 2020; 11():622862. PubMed ID: 33536925 [No Abstract] [Full Text] [Related]
20. Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database. Montastruc F; Duguet C; Rousseau V; Bagheri H; Montastruc JL Eur J Clin Pharmacol; 2014 Sep; 70(9):1123-7. PubMed ID: 24925091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]